Novartis Investigative Site

Rülzheim 76761

0 studies enrolling now · 1 studies all time

What they study most

Relapsing Forms of Multiple Sclerosis

Studies at this site

• Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis — Completed